4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-24-061083
Options or other derivatives
- Director acquired 21,980 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Milligan Sandra · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-14 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +21,980 | 21,980 | D |
Loading xslF345X05/ownership.xml…